Skip to main content
NT

Neuraptive Therapeutics

Neuraptive Therapeutics develops a novel PEG-fusion system and specialized drug delivery device for the repair of severed peripheral nerves, enhancing recovery speed and outcomes for patients with peripheral nerve injuries. Their surgical treatment kit, NTX-001, utilizes previously approved pharmaceutical ingredients to improve the effectiveness of nerve repair procedures in acute trauma and reconstructive surgeries.

Lafayette, United StatesFounded 201615700+ followers
Updated 20 months ago

Funding

$32M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

BF
Funding rounds are not available yet.

Founders

Product

Problem

Peripheral nerve injuries resulting from trauma or reconstructive surgeries often lead to incomplete or slow recovery, impacting patient function and quality of life. Current nerve repair techniques can be limited in their effectiveness, leading to suboptimal outcomes.

Solution

Neuraptive Therapeutics is developing NTX-001, a surgical treatment kit that combines a novel PEG-fusion system with a specialized drug delivery device to improve the repair of severed peripheral nerves. The PEG-fusion technology enhances the speed and quality of nerve reconnection, while the drug delivery device allows for targeted administration of active agents directly to the nerve. NTX-001 leverages previously approved pharmaceutical ingredients, aiming to improve nerve regeneration and functional recovery following peripheral nerve injuries. The kit is designed for use in both acute trauma and reconstructive nerve repair procedures.

Target Audience

The primary target audience includes surgeons specializing in peripheral nerve repair, such as those in plastic surgery, orthopedic surgery, and neurosurgery, who treat patients with traumatic nerve injuries or those undergoing reconstructive procedures.

Features

  • PEG-fusion system for enhanced nerve reconnection and improved outcomes
  • Specialized drug delivery device for topical administration of active agents to the nerve
  • NTX-001 surgical treatment kit comprised of sterile solutions with previously approved pharmaceutical ingredients
  • Microsurgical instruments designed specifically for nerve repair procedures
  • Designed for use in acute trauma and reconstructive surgeries
This profile is AI-generated and may contain inaccuracies.